Cargando…

Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension

BACKGROUND: The remodeling of the right heart in patients with chronic pulmonary hypertension (cPH) is associated with the appearance of electrocardiographic (ECG) abnormalities. We investigated the resolution of ECG markers of right ventricular hypertrophy (RVH) caused by acute and long‐term hemody...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piłka, Michał, Darocha, Szymon, Banaszkiewicz, Marta, Wieteska‐Miłek, Maria, Mańczak, Małgorzata, Mańczak, Rafał, Kędzierski, Piotr, Florczyk, Michał, Dobosiewicz, Anna, Torbicki, Adam, Kurzyna, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507443/ https://www.ncbi.nlm.nih.gov/pubmed/32335975 http://dx.doi.org/10.1111/anec.12758

Ejemplares similares

Prediction of Prognostic Hemodynamic Indices in Pulmonary Hypertension Using Non-Invasive Parameters
por: Mańczak, Rafał, et al.
Publicado: (2020)

Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Piłka, Michał, et al.
Publicado: (2021)

Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Banaszkiewicz, Marta, et al.
Publicado: (2021)

Circulating Blood-Based Biomarkers in Pulmonary Hypertension
por: Banaszkiewicz, Marta, et al.
Publicado: (2022)

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Kacprzak, Aneta, et al.
Publicado: (2021)

An unusual case of CTEPH treated by BPA in a patient with a single lung after cancer surgery
por: Darocha, Szymon, et al.
Publicado: (2022)

Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors
por: Wieteska-Miłek, Maria, et al.
Publicado: (2022)

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?
por: Florczyk, Michał, et al.
Publicado: (2017)

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023)

Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2020)

Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2021)

Long COVID syndrome after SARS‐CoV‐2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Wieteska‐Miłek, Maria, et al.
Publicado: (2023)

Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team
por: Siennicka, Anna, et al.
Publicado: (2019)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Kurzyna, Marcin, et al.
Publicado: (2015)

Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Precision medicine: The future of diagnostic approach to pulmonary hypertension?
por: Kedzierski, Piotr, et al.
Publicado: (2019)

Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Dominating Cause of Pulmonary Hypertension May Change Over Time—Diagnostic and Therapeutic Considerations in a Patient with Pulmonary Hypertension Due to Rheumatoid Arthritis with Lung Involvement
por: Szturmowicz, Monika, et al.
Publicado: (2021)

Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)
por: Kopeć, Grzegorz, et al.
Publicado: (2020)

Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies
por: Nowak, Marcin M., et al.
Publicado: (2022)

Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL)
por: Kopeć, Grzegorz, et al.
Publicado: (2021)

Cervical spine instability in the course of rheumatoid arthritis – imaging methods
por: Mańczak, Małgorzata, et al.
Publicado: (2017)

Electrocardiographic and other Noninvasive Hemodynamic Markers in Decompensated CHF Patients
por: Piccirillo, Gianfranco, et al.
Publicado: (2023)

ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension
por: Waligóra, Marcin, et al.
Publicado: (2018)

Alcohol Policies Affect Drinking Patterns—A Potentially New and Harmful Drinking Pattern in Consumers of Small Vodka Bottles (SVB) in Poland
por: Silczuk, Andrzej, et al.
Publicado: (2022)

Ultrasound and MRI of the foot in children and adolescents newly diagnosed with juvenile idiopathic arthritis
por: Posadzy, Magdalena, et al.
Publicado: (2023)

Hybrid treatment of massive pulmonary embolism by catheter-directed and surgical embolectomy
por: Pietrasik, Arkadiusz, et al.
Publicado: (2021)

High CD200 Expression on T CD4+ and T CD8+ Lymphocytes as a Non-Invasive Marker of Idiopathic Pulmonary Hypertension–Preliminary Study
por: Tomaszewski, Michał, et al.
Publicado: (2021)

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Pulmonary Hypertension Patients: Insights from the BNP-PL National Database
por: Mamzer, Aleksandra, et al.
Publicado: (2022)

Corrigendum to “ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension”
por: Waligóra, Marcin, et al.
Publicado: (2018)

Health-related quality of life in children with juvenile idiopathic arthritis – child’s and parent’s point of view
por: Mańczak, Małgorzata, et al.
Publicado: (2016)

MRI Findings in Hip in Juvenile Idiopathic Arthritis
por: Ostrowska, Monika, et al.
Publicado: (2021)

In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans
por: Szturmowicz, Monika, et al.
Publicado: (2010)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
por: Kurzyna, Marcin, et al.
Publicado: (2017)

Nutrition and quality of life referring to physical abilities – a comparative analysis of a questionnaire study of patients with rheumatoid arthritis and osteoarthritis
por: Grygielska, Jolanta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iqrh610s8urgsd1k6gkgl02m6p